ArticleCancer immunology, immunotherapy : CII2013

Identification of a novel HLA-A2-restricted mutated Survivin epitope and induction of specific anti-HCC CTLs that could effectively cross-recognize wild-type Survivin antigen.

Han Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.